EUVIMEDEUVIMED entdecken
Leserbrief

Effectiveness and safety of tofacitinib in patients with chronic pouchitis multirefractory to biologics

Mathieu Uzzan, Maria Nachury, Aurélien Amiot, Laurent Peyrin-Biroulet, Julien Kirchgesner, Yoram Bouhnik, GETAID TOFA-POUCH study group

Digestive and Liver Disease · 2023

DOI: 10.1016/j.dld.2023.04.028 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Digestive and Liver Disease, 2023. Verfasst von Mathieu Uzzan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Paris Est Créteil University UPEC, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Gastroenterology department, Fédération Hosp…. Hauptthemen laut MEDLINE: Pouchitis, Biological Products, Proctocolectomy, Restorative, Colitis, Ulcerative. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PouchitisBiological ProductsProctocolectomy, RestorativeColitis, UlcerativeHumansPiperidinesPyrimidines

Stichwörter der Autor:innen

Chronic pouchitisTofacitinibUlcerative colitis

Substanzen

Biological ProductstofacitinibPiperidinesPyrimidines

Autor:innen und Institutionen

  • Paris Est Créteil University UPEC, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Gastroenterology department, Fédération Hospitalo-Universitaire TRUE Innova Tive the Rapy for imm Une disord Ers,…
  • Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.
  • Department of Gastroenterology, Hopitaux Universitaires Bicêtre, AP-HP, Universite Paris Est Creteil and Universite Paris Saclay, INSERM, Centre for Research in Epidemiology and Population Health, Le Kremlin Bicêtre, Fr…
  • Lorraine University, Vandoeuvre-les-Nancy, France. University of Lorraine, CHRU-Nancy, Department of Gastroenterology, F-54000 Nancy, France University of Lorraine, Inserm, NGERE, F-54000 Nancy, France.
  • INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Department of Gastroenterology, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Department of Gastroenterology, Hopital Beaujon, AP-HP, Universite de Paris, France; Paris IBD Center, Groupe Hospitalier Privé Ambroise Paré-Hartmann, Neuilly-sur-Seine, France.

Zitieren

APA

Uzzan, M., Nachury, M., Amiot, A., Peyrin-Biroulet, L., Kirchgesner, J., Bouhnik, Y., & GETAID TOFA-POUCH study group (2023). Effectiveness and safety of tofacitinib in patients with chronic pouchitis multirefractory to biologics. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2023.04.028

Vancouver

Uzzan M, Nachury M, Amiot A, Peyrin-Biroulet L, Kirchgesner J, Bouhnik Y, et al. Effectiveness and safety of tofacitinib in patients with chronic pouchitis multirefractory to biologics. Digestive and Liver Disease. 2023. doi:10.1016/j.dld.2023.04.028

BibTeX
@article{Uzzan2023,
  author = {Uzzan, Mathieu and Nachury, Maria and Amiot, Aurélien and Peyrin-Biroulet, Laurent and Kirchgesner, Julien and Bouhnik, Yoram and GETAID TOFA-POUCH study group, GETAID TOFA-POUCH study group},
  title = {Effectiveness and safety of tofacitinib in patients with chronic pouchitis multirefractory to biologics},
  journal = {Digestive and Liver Disease},
  year = {2023},
  doi = {10.1016/j.dld.2023.04.028}
}
Kostenlos starten →